Vol. 182, No. 2, 1992 January 31, 1992
BIOCHEMICAL
BIOCHEMICAL
Received
RESEARCH COMMUNICATIONS Pages 947-952
CHARACTERIZATION OF BINDING SITES FOR DIHYDROPYRIDINE AND o-CONOTOXIN IN BRAIN OF ADULT CHICKEN
A. Zgaga-Griesz, University
AND BIOPHYSICAL
R. Woscholski,
P. Straub,
of Freiburg, Institute Gddecke AG, Mooswaldallee December
20,
of l-9,
H. Hug,
Molecular Cell 7800 Freiburg,
D. Marmel Biology, FRG
c/o
1991
Binding studies using the calcium channel blockers Summary: o-conotoxin and dihydropyridine revealed a rather equal amount of binding sites in brain from adult chicken. The o-conotoxin binding sites could be solubilized using digitonin, without substantial loss, whereas a great decrease in dihydropyridine binding sites was observed, indicating that both types of binding sites have different sensitivity to solubilization. In contrast to ion exchange chromatography where both binding sites comigrated, glycoprotein affinity chromatography led to a different partition of the binding sites in the flow through and eluate fractions. Our results indicate that both types of calcium channel blockers bind to different targets in adult chicken. 0 1992 Academic Press, Inc. Voltage dependent calcium channels (VDCC) play a key role in excitation-contraction and excitation-secretion coupling. With respect to their electrophysiological properties the VDCC have been classified as L-, N- and T-type channels (1). L-type specific calcium channel blockers like 1,4-dihydropyridines (DHP) e. g. PN 200-110 were useful1 tools for the characterization, purification and structure analysis of this channel type from different tissues (2, 3, 4). o-Conotoxin (GVIA), a poisonous peptide produced by the marine snake Conus geographus blocks the N-type and the L-type VDCC from neuronal tissue, as shown by electrophysiological techniques (5). Previous work using both VDCC-blockers revealed that brain tissue from juvenil chicken contains 5-times more GVIA- than DHP-binding sites (6). However, both types of binding sites from adult chicken are much less characterized. 1
To whom correspondence
should
be addressed.
Abbreviations: omega-conotoxin (GVIA), 1,4-dihydropyridines (DHP), Voltage dependent calcium channels (VDCC), wheat germ glutinine (WGA). 0006-291x/92 947
ag$1.50
Copyright 0 1992 by Academic Press, Inc. All rights of reproduction in any form reserved.
Vol.
182,
No.
2, 1992
BIOCHEMICAL
AND
BIOPHYSICAL
We therefore investigated the amount GVIA and DHP in brains from juvenil chicks types of binding sites using chromatographic
MATE-S
AND
RESEARCH
COMMUNICATIONS
of binding sites and characterized techniques.
for both
-0DS
The drugs and chemicals used and their sources are as folWGA-Sepharose 6MB (Pharlows: Digitonin (Sigma): DEAE-Sepharose, GVIA (Peptide Institute): ['H]PN 200macia); PN 200-110 (Sandoz), Adult chicken were received from a local 110, [""J]GVIA (Amersham). hatchery and immediately used for preparation of brain membranes as previously described (7). brain membranes DHP- and GVIA _'bind i na to u&xpbranes : Chicken were diluted to a final concentration of 4 mg/ml or 0.1 mg/ml for DHP or GVIA binding, respectively and incubated with the indicated concentrations of ['H]PN 200-110 and ["'"J]GVIA, according to the methods of Curtis and Catterall (8) or Barhanin et al. (9), respectively. VDCC-blockers bound to the membranes were collected using rapid filtration throught Whatman GF/C filters (postlabel Nonspecific binding was obtainded in the presence of 0.4 method). PM unlabeled PN 200-110 or 9 nM unlabeled GVIA, respectively. Specific binding was calculated as the difference of the determined total and nonspecific binding. Protein concentration was measured according to Bradford (10). Solubilizationofmembranes : Brain membranes were solubilized using 1.25 % (w/v) digitonin according to Curtis and Catterall (8). GVIA-binding was performed as described by Yamaguchi et al. (11) using gelfiltration for collection of the GVIA bound to solubilized membranes. DHP-binding of the solubilized membranes could not be performed using postlabel techniques as described for the membranes, because this type of binding sites is sensitive to solubilization (see Results and Discussion). We therefore labeled membranes with ['H]PN 200-110 prior to solubilization (prelabel method) as described above. In order to obtain the specific DHPbinding the membranes were divided in equal aliquots. One aliquot was labeled only with ['H]PN 200-110 (representing total binding), whereas the other aliqout was labeld with [3H]PN 200-110 in presence of 2 pM unlabeled PN 200-110 (representing nonspecific binding). Solubilized membranes were directly used for liquid scintillation counting for determination of the bound [3H]PN 200-110. Anion emue chromatogranhv: Membranes were labeled with [3H]PN 200-110 or [""J]GVIA (for nonspecific binding: with the corresponding unlabeled VDCC-blocker) prior to solubilization using the described prelabel method. The solubilized membranes were loaded onto 1 ml DEAE-Sepharose columns. Each column was washed and then stepwise eluted with increasing NaCl concentrations as indicated. DHP- and GVIA-binding was determined by counting aliquots with and without liquid scintillation, respectively. . * Afflnltv Membranes were divided in equal aliquots. One aliquot was used directly for solubilization, whereas the other aliqouts were used for DHP-labeling prior to solubilization. Each aliquot of solubilized membranes was loaded onto separate columns containing 1 ml wheat germ agglutinin (WGA)Sepharose. Each column was washed and then eluted as described (8). GVIA-binding was determined by gelfiltration as described for solubilization. DHP-binding was measured by liquid scintillation counting. 948
Vol.
182,
No.
2, 1992
Our
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
COMMUNICATIONS
studies
with the membranes of adult chicken ing sites with a Bmax of pmol/mg for DHP and GVIA, 0.536 + 0.271 pM for DHP equal
amount
using
juvenil
VDCC blockers DHP and GVIA using brain revealed a rather equal amount of bind0.403 + 0.11 pmol/mg or 0.315 + 0.124 repectively. The k, was 180 + 59 pM or and GVIA, respectively (Fig. 1). This of binding sites is in contrast to previous reports brain tissues, which revealed 5-fold more GVIA- than
DHP-binding
sites
precipitate
any
(6,
9).
However,
GVIA-binding
Hayakawa
sites
from
et
al.
adult
rabbit
brains using a L-type specific antibody. This and GVIA-binding occurs on different targets, were
used. Taken
during i)
their
both
types
led
to
of
we
binding
sites
a different
different
using
chicken
in
with
brains
1.25
present
from
adult
% digitonin. in
membranes
were
chicken,
could
be recoverd
prelabeled
with
of
the
bovine
that because
two
types
of
work (12, 13), our investigations
whereas
15 % of
not
conclude
other
the
the
after
(15). binding membranes
DHP-binding
solubilization,
[3H]PN 200-110
prior
ii)
investiga-
root ganglion two types of
we solubilized
Approximitly
membranes
can
by previous brain, since
used whole brain tissue (14) or dorsal In order to further characterize the
and
may change
ratio
cerebrum,
could
indicates that DHPwhen adult tissues
together,
which is supported distribution in
sites, performed
sites
if
observations
expression
binding
their were tions
these
development
(12)
sites only
to solubili-
b 300
500
PN 200.110
Figure 1. GVIA-binding
Concentration
-r
1000
(PM)
GVIA
specific PN 200-llOand Chicken brain membranes were incubated with the indicated concentrations of [3H]PN ZOO-110 (panel a) and [ 125J]GVIA (panel b). Bound (B) and free (F) label was separated by rapid filtration (post label method). In both cases nonspecific binding was less than 20 % of the total binding. The values are the mean + standard deviation of four independent experiments. The inserted blot shows the transformation of the data according to Scatchard (20). to
chicken
dependence
brain
of
(PM)
membranes.
949
Vol.
182,
No.
2,
1992
BIOCHEMICAL
AND
BIOPHYSICAL
RESEARCH
B (Imdlmg protein) 300
600
PN 200-110
COMMUNICATIONS
B (Imolhg protein)
900
0
1000
500
(PM)
PN 200-110
1500
(PM)
Ficfure 2. Comparison of specific DHP binding to membraneand solubiliaed fractions of chicken brain. Membranes were labeled with the indicated amounts of [3H]PN 200-110, bound and free label was separated by centrifugation (prelabel method). The amount of bound DHP was determined before (panel a) and after solubilization Unspecific binding was less than 20 % in membranes and (panel b). 50 % in solubilized brain fractions. The inserted blot shows the transformation of the data according to Scatchard (20).
zation
(Fig.2).
This
solubilization
of
and heart solubilization loss from
compared
to
the
same
the
DHP-binding to
in
contrast
sites
type
of
binding
(17)
the
be due
However, it is not unlikely caused by an interaction of
a corresponding
observed
(12, the
DHP-binding sites to solubilization derived
supports
detergent
interference that a lipid
that
both
from
further graphic techniques sites from muscle
with
muscle non-DHPcurrents
sensitivity subunit
inter-
this detergent sensitiviwith the calcium channel GVIA-binding sites coshown), indicating that sensitivity to the so-
binding
Two populations of 19), one of them contains DHP-binding site.
For
(2)
(8) reported that led also to a great
sites
(18). In contrast to the DHP-binding sites, uld be successful solubilized (data not both types of binding sites have different
described represents
successful muscle
investigations demonstrated that L-type VDCC modulate the calcium
could
which targets.
the
skeletal
This indicated that a higher sensitivity
action. ty is
lubilization, on different
to
from
Curtis and Catterall membranes from rat
sites. have
Since previous subunits of the and
is
DHP-binding
However, of brain
of DHP-binding neuronal tissues
tissue. binding (16)
(3).
observation
the
sites
are
located
N-type VDCC have been the al-subunit which
biochemical characterization we used chromatowhich were well established for DHP-binding tissues (2, 3). Solubilized membranes were loaded onto 1 ml DEAE-Sepharose column. After washing the column both types could be eluted at nearly the same salt concentration 950
Vol.
182, No. 2, 1992
-flow
BIOCHEMICAL
through
100
AND BIOPHYSICAL
200
300 NaCl
riuure
from
400
RESEARCH COMMUNICATIONS
500
1000
(mM)
3. Anion exchange chromatography of DliP- and GVIA-receptors chicken brain. Solubilized and membranes prelabeled with
[3H]PN 200-110 or [125 JIGVIA were loaded onto a DEAE-column and eluted with increasing concentrations of NaCl. The amount DHP- and GVIA-binding sites applied to the column was set to 100 %.
(0.2 M NaCl) with similar recoveries, indicating that both types have similar binding characteristics upon ion exchange chromatography (Fig. 3). In contrast to this observation, a comparable investigation using a glycoprotein affinity column revealed that both types of binding sites have different binding properties. Different amounts of both binding sites could be bound to the wheat germ agglutinin (WGA)-column. Most of the GVIA-binding sites (73.9 % of the loaded binding sites) bound to the lectin, whereas 62.3 % of the loaded DHP-binding sites were found in the flow through fraction. Since both binding sites were loaded under similar conditions, the different partitioning in the fractions of the glycoprotein affinity chromatography could be mainly due to a corresponding different degree of glycosylation, which again supports that both binding sites may be a different target. In summary our results support that the ligands GVIA and DHP have different binding sites, which is in agreement to corresponding investigations using brain tissues from adult rabbit and bovine (12, 19). In particular, we observed different sensitivity to solubilization and a different partitioning upon chromatography with a glycoprotein affinity column. In addition we determined rather equal amounts of the two types of binding sites indicating that either expression or distribution of the two types of binding sites
have
changed
during
development. 951
We therefore
conclude
that
Vol.
182, No. 2, 1992
the both VDCC-types of neuronal tissue.
BIOCHEMICAL
may play
AND BIOPHYSICAL
a so far
unknown
RESEARCH COMMUNICATIONS
role
in
development
REFERENCES 1) McCleskey, E. W., Fox, A. P., Feldman, D. H., Cruz, L. J., Olivera, B. M., Tsien, R. W. and Yoshikami, D. (1987) Proc. Natl. Acad. Sci. USA 84, 4327-4331. F. (1986) Eur. J. 2) Flockerzi, V., Oeken, H. J. and Hofmann, Biochem. 161, 217-224. 3) Mikamie, A. M., Imoto, K., Tanabe, T., Niidome, T., Mori, Y. , Takeshima, H., Marumiya, S. and Numa, S. (1989) Nature 340, 230-233. 4) Campbell, K. P., Leung, A. T. and Sharp, A. H. (1988) TINS 11, 425-430. 5) Nowycky, M. C., Fox, A. P. and Tsien, R. W. (1985) Nature 316, 440-443. 6) Takahshi, M. and Fujimoto, Y. (1989) Biochem. Biophys. Res. Commun. 163, 1182-1188. 7) Glossmann, H. and Ferry, D. R. (1985) Methods in Enzymol. 109, 513-550. 8) Curtis, B. M. and Catterall, W. A. (1983) J. Biol. Chem. 258, 7280-7283. 9) Barhanin, J., Schmid, A. and Lazdunski, M. (1988) Biochem. Biophys. Res. Commun. 150, 1051-1062. 10) Bradford, M. M. (1976) Anal. Biochem. 72, 248-254. 11) Yamaguchi, T., Saisu, H., Mitsui, H. and Abe, T. (1988) J Biol. Chem. 263, 9491-9498. 12) Hayakawa, N., Morita, T., Yamaguchi, T., Mitsui, H., Mori,K. J., Saisu, H. and Abe T. (1990) Biochem. Biophys. Res. Commun. 173, 483-489. 13) Aosaki, T. and Kasai, H. (1989) Eur. J. Physiol. 414, 150-m. 14) Cruz, L. J. and Olivera, B. M. (1986) J. Bio. Chem. 261, 623+ 6233. 15) Feldman, D. H., Olivera, B. M. and Yoshikamie D. (1987) Febs Letters 214, 295-300. 16) Singer, D., Biel, M., Lotan, I., Flockerzi, V., Hofmann, F. and Dascal, N. (1991) 253, 1553-1557. 17) Woscholski, R. and Marme, D. (1991) Cell. Signalling, in pzees 18) Glossmann, H. and Ferry, D. R. (1983) Nauny-Schmiedebergs Arch. Pharmacol. 323, 279-291. 19) Ahlijanian, K., M. Striessnig, J. and Catterall, W. A. (1991) J. Biol. Chem. 266, 20192-20197. 20) Scatchard, G. (1949) Annu. N. Y. Acad. Sci. 51, 660-672.
952